Avid Bioservices Inc (CDMO)

[InternetForumUser]

Partnership and Risk:

I have seen many posts on this board about "RISK" being the reason that Peregrine has not partnered with anyone. However, the same posters will state that this "RISK" will be removed once there is data from other trials like the P3 and the Melanoma trials.

Hasn't Peregrine Management stated that the P2 Data is better than what has been released? How can there be more risk now than before? The information has been stated by Shan and Garnick, which is being said from the proverbial "Horses Mouth".

If the P2 Data is better than what has been released, then Abbvie should have more reasons to partner now than before.

Something does not add up with some of the information which is posted. Why would a BP need to wait for more trial information to validate the data? Didn't Peregrine Management already validate the data and state it was better?

The only reason that I can come up with is that Management is not trustworthy; therefore, BP's do not believe the new and revised P2 data.